CRIMALDDI: platform technologies and novel anti-malarial drug targets

被引：0
|
作者：
Henri Vial
Donatella Taramelli
Ian C Boulton
Steve A Ward
Christian Doerig
Kelly Chibale
机构：
[1] Université Montpellier 2,Centre National de la Recherche Scientifique, UMR 5235
[2] Università di Milano,Dipartmento di Scienze Farmacologiche e Biomolecolari
[3] TropMed Pharma Consulting Ltd,Department of Microbiology
[4] Liverpool School of Tropical Medicine,Department of Chemistry
[5] School of Biomedical Sciences,undefined
[6] Monash University,undefined
[7] University of Cape Town,undefined
来源：
Malaria Journal | / 12卷
关键词：
CRIMALDDI; Malaria; Drug discovery; Research agenda; Novel targets; Enabling technologies; Prioritization;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The Coordination, Rationalization, and Integration of antiMALarial drug Discovery & Development Initiatives (CRIMALDDI) Consortium, funded by the EU Framework Seven Programme, has attempted, through a series of interactive and facilitated workshops, to develop priorities for research to expedite the discovery of new anti-malarials. This paper outlines the recommendations for the development of enabling technologies and the identification of novel targets.
引用
收藏
相关论文
共 50 条
  • [41] Generation of the potent anti-malarial drug artemisinin in tobacco
    Moran Farhi
    Elena Marhevka
    Julius Ben-Ari
    Anna Algamas-Dimantov
    Zhuobin Liang
    Vardit Zeevi
    Orit Edelbaum
    Ben Spitzer-Rimon
    Hagai Abeliovich
    Betty Schwartz
    Tzvi Tzfira
    Alexander Vainstein
    Nature Biotechnology, 2011, 29 : 1072 - 1074
  • [42] Engineering microbes for anti-malarial drug production.
    Keasling, JD
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U182 - U183
  • [43] Measuring windows of selection for anti-malarial drug treatments
    Kay, Katherine
    Hastings, Ian M.
    MALARIA JOURNAL, 2015, 14
  • [44] Anti-malarial priorities
    Sampson, R. A. S.
    CHEMISTRY WORLD, 2007, 4 (09): : 40 - 40
  • [45] ANTI-MALARIAL DRUGS
    GARRY, D
    IRISH MEDICAL JOURNAL, 1985, 78 (10) : 299 - 299
  • [46] ANTI-MALARIAL DRUGS
    GAYRAL, P
    LYON PHARMACEUTIQUE, 1979, 30 (03): : 209 - 219
  • [47] Correlation between anti-malarial and anti-haemozoin activities of anti-malarial compounds
    Dao Ngoc Hien Tam
    Gehad Mohamed Tawfik
    Amr Ehab El-Qushayri
    Ghaleb Muhammad Mehyar
    Sedralmontaha Istanbuly
    Sedighe Karimzadeh
    Vo Linh Tu
    Ranjit Tiwari
    Truong Van Dat
    Phuong Thuy Viet Nguyen
    Kenji Hirayama
    Nguyen Tien Huy
    Malaria Journal, 19
  • [48] Enoyl reductases as targets for the development of anti-tubercular and anti-malarial agents
    Oliveira, J. S.
    Vasconcelos, I. B.
    Moreira, I. S.
    Santos, D. S.
    Basso, L. A.
    CURRENT DRUG TARGETS, 2007, 8 (03) : 399 - 411
  • [49] NOVEL SUBSTITUTED QUINOLINES WITH POSSIBLE ANTI-MALARIAL ACTIVITY
    ZAYED, A
    ZOOROB, HH
    ELWASSIMI, MT
    PHARMAZIE, 1978, 33 (09): : 572 - 575
  • [50] Synthesis and biological evaluation of a novel anti-malarial lead
    Nicholas L. Hammond
    Seoung-ryoung Choi
    Paulo Carvalho
    Hua Liu
    Shabana Khan
    Mitchell A. Avery
    Medicinal Chemistry Research, 2011, 20 : 401 - 407
12345